Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;48(1):52-108.
doi: 10.1080/10408444.2017.1351420. Epub 2017 Aug 17.

Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future

Melissa A Davidson  1   2 , Donald R Mattison  2   3 , Laurent Azoulay  4   5 , Daniel Krewski  1   2   3   6
Affiliations
Review

Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future

Melissa A Davidson et al. Crit Rev Toxicol. 2018 Jan.

Abstract

Thiazolidinedione (TZD) drugs used in the treatment of type 2 diabetes mellitus (T2DM) have proven effective in improving insulin sensitivity, hyperglycemia, and lipid metabolism. Though well tolerated by some patients, their mechanism of action as ligands of peroxisome proliferator-activated receptors (PPARs) results in the activation of several pathways in addition to those responsible for glycemic control and lipid homeostasis. These pathways, which include those related to inflammation, bone formation, and cell proliferation, may lead to adverse health outcomes. As treatment with TZDs has been associated with adverse hepatic, cardiovascular, osteological, and carcinogenic events in some studies, the role of TZDs in the treatment of T2DM continues to be debated. At the same time, new therapeutic roles for TZDs are being investigated, with new forms and isoforms currently in the pre-clinical phase for use in the prevention and treatment of some cancers, inflammatory diseases, and other conditions. The aims of this review are to provide an overview of the mechanism(s) of action of TZDs, a review of their safety for use in the treatment of T2DM, and a perspective on their current and future therapeutic roles.

Keywords: Thiazolidinedione; adverse effects; bone fracture; cancer; diabetes; drug safety; heart failure; hepatotoxicity; mechanism; myocardial infarction.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

Substances

  NODES
INTERN 2
twitter 2